The biotech company's revenues had fallen to as low as Rs 50 cr after it lost a WHO contract, but now it hopes to reach Rs 700 cr in two years. t's sheer luck that made you succeed in an otherwise completely risky endeavour," is what K Anji Reddy, founder and chairman of Dr Reddy's Laboratories, used to tell K I Varaprasad Reddy, founder of vaccine manufacturing company Shantha Biotechnics.